Holders — by stockHoldings — by fund
ACORN CAPITAL ADVISORS, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002054410
$366.5M
disclosed book value
20
positions
21.9%
largest position share
Positions, as of 2026-06-30
top 20 of 20 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 1.1M | $80.4M | 21.9% |
| 2 | UROGEN PHARMA LTD | 1.7M | $61.6M | 16.8% |
| 3 | TRVITREVI THERAPEUTICS INC | 2.1M | $40.0M | 10.9% |
| 4 | CADLCANDEL THERAPEUTICS INC | 3.5M | $36.0M | 9.8% |
| 5 | PBYIPUMA BIOTECHNOLOGY INC | 4.1M | $33.5M | 9.1% |
| 6 | JBIOJADE BIOSCEINCES INC | 986,760 | $21.9M | 6% |
| 7 | BCAXBICARA THERAPEUTICS | 643,381 | $19.1M | 5.2% |
| 8 | KPTIKARYOPHARM THERAPEUTICS INC | 1.5M | $14.8M | 4% |
| 9 | OKURONKURE THERAPEUTICS INC | 2.8M | $12.9M | 3.5% |
| 10 | HELPHELUS PHARMA INC. | 1.5M | $10.2M | 2.8% |
| 11 | TARAPROTARA THERAPEUTICS INC | 1.8M | $6.7M | 1.8% |
| 12 | AURAAURA BIOSCIENCES INC | 929,077 | $6.6M | 1.8% |
| 13 | LONALEONABIO, INC. | 634,539 | $5.8M | 1.6% |
| 14 | VSTMVERASTEM INC | 1.5M | $5.6M | 1.5% |
| 15 | WHWKWHITEHAWK THERAPEUTICS INC | 1.1M | $5.2M | 1.4% |
| 16 | QTTBQ32 BIO INC. | 216,171 | $2.8M | 0.8% |
| 17 | ENGNEUGENE THERAPEUTICS | 1.3M | $2.2M | 0.6% |
| 18 | JSPRJASPER THERAPEUTICS | 1.4M | $604,027 | 0.2% |
| 19 | BCABGBPBIOATLA INC | 108,126 | $447,645 | 0.1% |
| 20 | MNLOUSDVYNE THERAPEUTICS INC | 1,425 | $926 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.